Africa - Asia - Brazil - Canada - Central and East Africa - Colombia - Cuba - Europe - France - Germany - Ghana - India - International - Italy - Low and middle income countries - Low-income countries - Malawi, Uganda - Middle East - Nigeria - Nigeria, United States - Oman - Republic of the Congo - Sao Tome and Principe - Saudi Arabia - Sierra Leone - Sub-Saharan Africa - Sudan - Switzerland - Tanzania - United Kingdom - United States - WHO - {Related topics}

Africa

• African Health Sciences
  • Frequency of red blood cell allo-immunization in transfused patients with sickle cell disease in Africa: a systematic review with meta-analysis [2025]

• American Journal of Hematology
  • Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview [2026]

• BMC Medicine
  • Caring for Africa’s sickle cell children: will we rise to the challenge? [2020]

• Neurology
  • Neurologic complications of sickle cell disease in Africa [2017]

• PLOS One
  • Burden of sickle cell anemia in Africa: A systematic review and meta-analysis [2025]

• SickleInAfrica
  • Barriers to sickle cell disease care: a biopsychosocial analysis mapped to the standards of care guidelines by the sickle pan African research consortium [2026]
  • Assent, parental consent and reconsent for health research in Africa: thematic analysis of national guidelines and lessons from the SickleInAfrica registry [2022]

• WHO African Region
  • WHO sickle package of interventions for sickle cell disease management [2024]
  • Progress in the implementation of the African Region sickle-cell strategy 2010–2020: information document [2020]
  • Sickle-Cell Disease: a strategy for the WHO African Region [2011]
  • Sickle-Cell Disease in the African Region: Current Situation and the Way Forward Report of the Regional Director [2006]
  • Sickle Cell Disease

Asia

• Neurology Research International
  • Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis [2021]

Brazil

• Acta Cirúrgica Brasileira
  • Epidemiological profile trends and cost of sickle cell disease in Brazil from 2008 to 2022 [2025]

• Cadernos de Saúde Pública
  • Social inequalities in the temporal trend of mortality from sickle cell disease in Brazil, 1996-2019 [2023]

• Ciência & Saúde Coletiva
  • Àgô Sankofa: an overview of the progression of sickle cell disease in Brazil in the past two decades [2024]

• Hematology, Transfusion and Cell Therapy
  • Guidelines on sickle cell disease: primary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines project: Associação Médica Brasileira - 2021 [2022]

• Revista Brasileira de Enfermagem
  • Analysis of the temporal trend of mortality from sickle cell anemia in Brazil [2022]

Canada

• Canadian Paediatric Society
  • Acute complications in children with sickle cell disease: Prevention and management [2022]

• CMAJ
  • Red blood cell transfusion in sickle cell disease [2023]

Central and East Africa

• Lancet Haematology
  • Incidence of clinically diagnosed infections in children with sickle cell anaemia treated with oral hydroxyurea in Angola, DR Congo, Kenya, and Uganda: a retrospective cohort study from the REACH trial [2026]

Colombia

• Orphanet Journal of Rare Diseases
  • Mortality trends and socioeconomic inequalities in sickle cell disease in Colombia, 2012-2023: a population-based study [2026]

Cuba

• MEDICC Review
  • Sickle cell anemia in Cuba: prevention and management, 1982-2018 [2019]

Europe

• European Hematology Association
  • Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference [2025]

France

• Frontiers in Public Health
  • Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires [2023]

• Haematologica
  • Severity and burden of sickle cell disease in France: a nationwide real-world study [2023]
  • Mortality in children with sickle cell disease in mainland France from 2000 to 2015 [2020]

• PLOS One
  • Modeling the public health impact of voxelotor in the management of sickle cell disease in France [2023]
  • Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database [2021]

• Scientific Reports
  • Nationwide retrospective study of critically ill adults with sickle cell disease in France [2021]

• Transfusion and Apheresis Science
  • Position paper on advancing sickle cell disease management in France by bridging the clinical practices and guidelines through expert insights [2024]

Germany

• Annals of Hematology
  • Sickle cell disease in Germany - trends in epidemiology, healthcare utilization and disease burden from 2015 to 2024: a claims data analysis [2026]

Ghana

• BMC Nephrology
  • Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana [2015]

• BMJ Open
  • Time trends, sociodemographic and health factors associated with discharge and length of stay of hospitalised patients with sickle cell disease in Ghana: a retrospective analysis of national routine health database [2021]

• British Journal of Haematology
  • Effectiveness of hydroxyurea (hydroxycarbamide) in a national sickle cell disease programme in Ghana [2025]

• Pan African Medical Journal
  • Controlling sickle cell disease in Ghana – ethics and options [2011]

• PLOS One
  • Healthcare providers' knowledge on sickle cell disease and its management: A pre- and post-training test evaluation outcome [2025]

• Seminars in Hematology
  • Access to essential therapy for sickle cell disease in Africa: Experience from a national program in Ghana [2023]

• SickleInAfrica
  • Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana [2022]

• Value in Health Regional Issues
  • Cost-Effectiveness of Hydroxyurea for Treatment of Children With Sickle Cell Anemia in Ghana [2026]

India

• Archives of Public Health
  • India's digital-first approach to sickle cell disease elimination [2026]

• BMJ Global Health
  • Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action [2021]

• Hematology: the American Society of Hematology Education Program
  • Sickle cell disease in India: the journey and hope for the future [2024]

• Indian Academy of Pediatrics
  • Practicing Pearls for Sickle Cell Disease Management [2022]

• Indian Journal of Medical Research
  • The Indian experience with hydroxyurea in sickle cell disease: A 25-year systematic review [2025]
  • A systematic review on hydroxyurea therapy for sickle cell disease in India [2022]
  • Evolving locally appropriate models of care for Indian sickle cell disease [2016]
  • Sickle cell disease in tribal populations in India [2015]

• PLOS One
  • Strengthening the National Sickle Cell Elimination Mission through universal access to point-of-care screening test [2026]

• Scientific Reports
  • The spatial epidemiology of sickle-cell anaemia in India [2018]

International

• American Journal of Hematology
  • Globalization in clinical drug development for sickle cell disease [2025]

• Asian Journal of Andrology
  • Reproductive function and sperm parameters in men with sickle cell disease: a systematic review [2026]

• Blood Advances
  • Primary and secondary stroke prophylaxis in children with sickle cell anemia: a meta-analysis [2026]
  • Cortisol in sickle cell disease: a systematic review and meta-analysis [2025]

• Blood Reviews
  • Point-of-care diagnostic test accuracy in children and adolescents with sickle cell disease: A systematic review and meta-analysis [2025]

• BMC Medical Research Methodology
  • The use of race and ethnicity in sickle cell disease research [2025]

• Haematologica
  • The modern use of hydroxyurea for children with sickle cell anemia [2025]
  • Infections in sickle cell disease [2025]
  • Environmental determinants of severity in sickle cell disease [2015]

• Indian Journal of Medical Research
  • Genetic patterns & public health implications of sickle cell anaemia across populations: A systematic review [2025]

• International Hemoglobinopathy Research Network
  • Genetic Modifiers Associated with Vaso-Occlusive Crises and Acute Pain Phenomena in Sickle Cell Disease: A Scoping Review [2025]
  • Systematic Review of Genetic Modifiers Associated with the Development and/or Progression of Nephropathy in Patients with Sickle Cell Disease [2024]
  • Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology [2024]
  • Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review [2024]

• International Journal of Molecular Sciences
  • Relevance of Plasma Homocysteine and Methylenetetrahydrofolate Reductase 677TT Genotype in Sickle Cell Disease: A Systematic Review and Meta-Analysis [2022]

• International Journal of Nursing Studies
  • Palliative care needs of adults severely affected by sickle cell disease: A mixed-methods systematic review [2026]

• JAMA Network Open
  • Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis [2023]

• Journal of Postgraduate Medicine
  • Assessing and managing iron deficiency anemia in sickle cell disease: Insights from a systematic review and meta-analysis [2025]

• Lancet Haematology
  • Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021 [2023]

• Mediterranean Journal of Hematology and Infectious Diseases
  • Current Issues and Options for Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease: An Update for Health Care Professionals [2020]

• Molecular Therapy
  • Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapy [2025]

• Molecular Therapy Methods & Clinical Development
  • Consensus-driven target product profiles for curative sickle cell disease gene therapies [2024]

• Pain
  • Blood-based protein biomarkers of sickle cell disease pain: a systematic review and meta-analysis [2026]

• Reproductive Health
  • Impact of sickle cell anaemia on reproductive health: a narrative review [2025]

• Transfusion and Apheresis Science
  • Global burden of transfusion in sickle cell disease [2023]

• Vox Sanguinis
  • Quality of life in people with sickle cell disease treated with automated red blood cell exchange [2025]

Italy

• British Journal of Haematology
  • Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned [2021]

• Italian Journal of Pediatrics
  • The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape [2025]

• Orphanet Journal of Rare Diseases
  • Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood [2013]

Low and middle income countries

• American Journal of Tropical Medicine and Hygiene
  • Fever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs [2020]

• BMJ Open
  • Self-management needs, strategies and support for individuals with sickle cell disease in developing countries: a scoping review [2024]

• British Journal of Haematology
  • The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low- and middle-income countries [2025]

• Expert Review of Hematology
  • Strategies to increase access to basic sickle cell disease care in low- and middle-income countries [2022]

Low-income countries

• Archives of Disease in Childhood
  • Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries [2013]

Malawi, Uganda

• BMC Public Health
  • The economic burden and catastrophic health expenditures among children with sickle cell anaemia on households in malaria-endemic areas: insights from Uganda and Malawi [2025]

Middle East

• Indian Journal of Medical Research
  • Sickle cell disease in Middle East Arab countries [2011]

Nigeria

• Advances in Hematology
  • Hypertransfusion Therapy in Sickle Cell Disease in Nigeria [2014]

• Anemia
  • Management of Sickle Cell Disease: A Review for Physician Education in Nigeria (Sub-Saharan Africa) [2015]

• BMC Medicine
  • Association of sickle cell disease with anthropometric indices among under-five children: evidence from 2018 Nigeria Demographic and Health Survey [2021]

• Demographic and Health Surveys
  • Analysis of Sickle Cell Genotypes of Young Children in Nigeria Using the 2018 DHS Survey [2020]

• Federal Ministry of Health and Social Welfare
  • National guideline for the control and management of sickle cell disease [2014]

• Systematic Reviews
  • Prevalence of sickle cell disease and sickle cell traits among children and adolescents in Nigeria: a systematic review and meta-analysis [2025]

Nigeria, United States

• Hemoglobin
  • Comparison of Patients from Nigeria and the USA Highlights Modifiable Risk Factors for Sickle Cell Anemia Complications [2014]

Oman

• Acta Biomedica
  • The prevalence of sickling abnormality in Oman: A review of relevant publications [2022]

Republic of the Congo

• Anemia
  • Sickle-Cell Disease Healthcare Cost in Africa: Experience of the Congo [2016]

Sao Tome and Principe

• BMC Public Health
  • Sickle cell trait in São Tomé e Príncipe: a population-based prevalence study in women of reproductive age [2024]

Saudi Arabia

• Annals of Saudi Medicine
  • Epidemiology of sickle cell disease in Saudi Arabia [2011]

• Saudi Pharmaceutical Journal
  • Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review [2021]

Sierra Leone

• PLOS One
  • Trends in the burden of sickle cell disorders in Sierra Leone, 1990-2023: An analysis of Global Burden of Disease Study 2023 estimates [2026]

Sub-Saharan Africa

• American Journal of Hematology
  • The Epidemiology of Sickle Cell Disease in Sub-Saharan Africa: Current Knowledge and Gaps to be Filled [2026]
  • Genetics and Genomics in Sickle Cell Disease in Africa [2026]
  • Creative and Adaptive Solutions for Early Diagnosis of Sickle Cell Disease in Sub-Saharan Africa [2026]

• Annals of Global Health
  • Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions? [2023]

• Annals of Hematology
  • Use of hydroxyurea in French-speaking Sub-Saharan Africa [2025]

• Blood
  • Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa [2023]

• BMC Nutrition
  • Nutritional perspectives on sickle cell disease in Africa: a systematic review [2021]

• BMC Public Health
  • Update on the practice of premarital screening for sickle cell traits in Africa: a systematic review and meta-analysis [2024]

• Expert Review of Hematology
  • Treating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based management [2025]

• Lancet Child & Adolescent Health
  • Prevalence estimates of sickle cell disease among children and adolescents in sub-Saharan Africa: a systematic review and modelling analysis [2026]

• Seminars in Hematology
  • Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa [2023]

• SickleInAfrica
  • Strengthening global partnerships for sustainable sickle cell disease care: insights from SickleInAfrica at the 77th United Nations General Assembly and the US-Africa Leaders' Summit [2025]
  • Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica [2023]
  • SickleInAfrica [2020]

Sudan

• Pan African Medical Journal
  • The ethnic distribution of sickle cell disease in Sudan [2014]

Switzerland

• Swiss Medical Weekly
  • Sickle cell disease today: a 75-year journey from "first molecular disease" to "first gene-editing therapy" [2024]

Tanzania

• Bulletin of the World Health Organization
  • Surveillance for sickle cell disease, United Republic of Tanzania [2020]

• SickleInAfrica
  • Development of the sickle Pan-African research consortium registry in Tanzania: opportunity to harness data science for sickle cell disease [2023]

• Tropical Medicine & International Health
  • Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality [2014]

United Kingdom

• Association of Anaesthetists
  • Guideline on the peri-operative management of patients with sickle cell disease: Guideline from the Association of Anaesthetists [2021]

• BMJ Open
  • Single-round modified Delphi consensus to optimise the care of patients with sickle cell disease across multidisciplinary teams within the NHS [2026]

• British Society for Haematology
  • Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease [2018]
  • Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects [2017]
  • Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion [2017]
  • Guideline on the management of acute chest syndrome in sickle cell disease [2015]

• Health and Social Care Delivery Research
  • Understanding the health-care experiences of people with sickle cell disorder transitioning from paediatric to adult services: This Sickle Cell Life, a longitudinal qualitative study [2020]

• National Institute for Health and Care Excellence
  • Sickle cell disease: managing acute painful episodes in hospital [2026]
  • Exagamglogene autotemcel for treating severe sickle cell disease in people 5 years and over [2026]
  • Spectra Optia for automatic red blood cell exchange in patients with sickle cell disease [2016]
  • Sickle cell disease [2014]

• NHS England
  • Plerixafor use in patients with sickle cell disease (SCD) who are eligible for treatment with exagamglogene autotemcel (ages 12 years and above) [2025]
  • Allogeneic haematopoietic stem cell transplantation for adults with sickle cell disease [2020]

• Royal College of Emergency Medicine
  • Management of Acute Presentations of Sickle Cell Disease in the Emergency Department [2024]

• Royal College of Pathologists
  • Guidelines on autopsy practice: Autopsy in sickle cell disease and sickle trait [2023]

United States

• Advances in Therapy
  • Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States [2023]

• American Academy of Pediatrics
  • Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report [2024]

• American Journal of Hematology
  • An integrated therapeutic approach to sickle cell disease management beyond infancy [2023]
  • Evidence gaps in the management of sickle cell disease: A summary of needed research [2015]

• American Society for Transplantation and Cellular Therapy
  • Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy [2026]

• American Society of Hematology
  • American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation [2021]
  • American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support [2020]
  • American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults [2020]
  • American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain [2020]
  • American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease [2019]
  • 2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations [2019]
  • Clinical Practice Guidelines on Sickle Cell Disease

• American Thoracic Society
  • An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease [2014]

• Annals of Emergency Medicine
  • Trends in Sickle Cell Disease–Related Mortality in the United States, 1979 to 2017 [2020]

• Annals of Hematology
  • A review on disease modifying pharmacologic therapies for sickle cell disease [2025]

• Annals of Internal Medicine
  • Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States [2023]

• Blood Advances
  • Informed shared decision-making or rigid eligibility and exclusion criteria for gene therapy for sickle cell disease? [2026]
  • Cure Sickle Cell Initiative recommendations on common data elements for sickle cell disease gene therapy trials [2026]
  • National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease [2025]
  • Is allogeneic transplantation for sickle cell disease still relevant in the era of gene therapy? [2025]
  • Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease [2025]
  • A road map for uniform, comprehensive long-term follow-up after curative therapy for sickle cell disease [2025]
  • Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries [2023]
  • Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception [2023]
  • Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects [2020]

• BMJ Open
  • Characterisation of medical conditions of children with sickle cell disease in the USA: findings from the 2007-2018 National Health Interview Survey (NHIS) [2023]

• British Journal of Haematology
  • Sickle cell anaemia therapy in 2025 [2025]

• Centers for Disease Control and Prevention
  • Vital Signs: Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents — Selected U.S. States, 2019 [2022]
  • Surveillance for Sickle Cell Disease — Sickle Cell Data Collection Program, Two States, 2004–2018 [2022]
  • CDC Grand Rounds: Improving the Lives of Persons with Sickle Cell Disease [2017]
  • Sickle Cell Disease
  • Preventing Sickle Cell Anemia Complications in Children

• Cytotherapy
  • Gene therapy for sickle cell disease: recent advances, clinical trials and future directions [2025]

• Drugs & Aging
  • Management of Older Adults with Sickle Cell Disease: Considerations for Current and Emerging Therapies [2023]

• Global Pediatric Health
  • Barriers to Pediatric Sickle Cell Disease Guideline Recommendations [2019]

• Hematology: the American Society of Hematology Education Program
  • The right patient, the right treatment: tailoring sickle cell disease care [2025]
  • Optimizing the right time to start sickle cell therapies [2025]
  • Practical guide for disease-modifying medication management of children and adolescents with sickle cell disease [2024]

• Institute for Clinical and Economic Review
  • Sickle Cell Disease

• International Journal of Environmental Research and Public Health
  • Analysis of the 2007-2018 National Health Interview Survey (NHIS): Examining Neurological Complications among Children with Sickle Cell Disease in the United States [2023]

• JAMA Health Forum
  • Rethinking Care Models for Young Adults With Sickle Cell Disease [2023]

• JAMA Network Open
  • National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance: A Consensus Statement [2025]

• Journal of the National Medical Association
  • Implicit bias in pain management: The intersection of stigma, race, and chronic disease in sickle cell disease [2026]

• Journal of Women's Health
  • Postpartum Tubal Sterilization in Sickle Cell Disease in the 2012-2019 National Inpatient Sample [2025]

• Molecular Therapy
  • Genome editing strategies for targeted correction of ß-globin mutation in sickle cell disease: From bench to bedside [2025]

• National Academies of Sciences, Engineering, and Medicine
  • Sickle Cell Disease in Social Security Disability Evaluations [2026]
  • Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings [2025]
  • Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action [2020]

• National Commission on Correctional Health Care
  • Care for People With Sickle Cell Disease in Correctional Settings [2025]

• National Heart, Lung, and Blood Institute
  • Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014 [2014]
  • Sickle Cell Disease

• Pediatric Blood & Cancer
  • Practice Patterns for Neuroimaging and Transfusion Therapy for Management of Neurologic Complications in Sickle Cell Anemia: DISPLACE Consortium [2020]

• Pediatrics
  • Prioritizing Sickle Cell Disease [2022]

• PharmacoEconomics
  • Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States [2024]

• PLOS One
  • Barriers and facilitators to healthcare utilization amongst people living with sickle cell disease in the United States: A scoping review [2026]
  • What does it mean to be affiliated with care?: Delphi consensus on the definition of "unaffiliation" and "specialist" in sickle cell disease [2022]
  • Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study [2022]
  • Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006–2010 [2016]

• Public Health Reports
  • A National Measurement Framework to Assess and Improve Sickle Cell Care in 4 US Regions [2020]

• Scientific Reports
  • Multi-center retrospective study of children with sickle cell disease admitted to pediatric intensive care units in the United States [2023]

• Stem Cells Translational Medicine
  • Hematopoietic stem cell therapy with gene modification to treat sickle cell disease [2025]

WHO

• World Health Organization
  • WHO consolidated guidelines for the management of common childhood illness: management of sickle-cell disease in children and adolescents [2026]
  • Target product profile for formulations of hydroxyurea for the management of sickle cell disease in children [2026]
  • Paediatric drug optimization for sickle cell disease: meeting report, 8-10 September 2025 [2026]
  • Sickle-cell anaemia [2006]
  • Sickle-cell disease: Fact sheet

{Related topics}

• Topic
  • Neonatal hematologic diseases
  • Hemoglobinopathies
  • Hematologic diseases in pregnancy, anemia in pregnancy
  • Anemia